TF
Tokali, Feyzi Sinan
18 yayın · 476 atıf · 2022–2026
Yayın
18
Atıf
476
Yıllar
5
Yayınlar
| Başlık | Yıl | Tip | Atıf |
|---|---|---|---|
|
Morpholine-modified thiosemicarbazones and thiazolidin-4-ones against Alzheimer's key enzymes: From synthesis to inhibition
|
2026 | Article | 11 |
|
Targeting cholinergic dysfunction and neuroinflammation through rationally designed Thieno[3,2-d]pyrimidine hybrids
|
2026 | Article | 0 |
|
Sulfonyl Hydrazone Derivatives Targeting Glutathione Reductase: A Potential Strategy for Redox Modulation in Cancer
|
2025 | Article | 0 |
|
Quinazolin-4(3<i>H</i>)-One-Based New Glitazones as Dual Inhibitors of α-Glucosidase and Aldose Reductase: Comprehensive Approaches for Managing Diabetes Mellitus and Its Complications
|
2025 | Article | 18 |
|
Development of phenolic Mannich bases as α-glucosidase and aldose reductase inhibitors:<i> In</i><i> vitro</i> and<i> in</i><i> silico</i> approaches for managing diabetes mellitus and its complications
|
2025 | Article | 28 |
|
Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality
|
2025 | Article | 22 |
|
Design, synthesis, and biological studies of isoniazid-based hydrazone Derivatives: Antibacterial, anticancer, and enzyme inhibitory properties
|
2025 | Article | 12 |
|
Sulfonamide derivatives with benzothiazole scaffold: Synthesis and carbonic anhydrase I-II inhibition properties
|
2024 | Article | 10 |
|
Novel hydrazones derived from anthranilic acid as potent cholinesterases and α-glycosidase inhibitors: Synthesis, characterization, and biological effects
|
2024 | Article | 26 |
|
Synthesis of quinazoline derivatives with new phenolic moieties: in vitro and in silico evaluations as alternative polyphenol oxidase inhibitors
|
2024 | Article | 3 |
|
Synthesis, characterization and sensor properties of a new sulfonyl hydrazone derivative molecule: potentiometric determination of Pb(II) ions
|
2024 | Article | 9 |
|
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors
|
2023 | Article | 88 |
|
Novel Quinazolinone Derivatives: Potential Synthetic Analogs for the Treatment of Glaucoma, Alzheimer's Disease and Diabetes Mellitus
|
2023 | Article | 40 |
|
Synthesis of new carboxylates and sulfonates containing thiazolidin-4-one ring and evaluation of inhibitory properties against some metabolic enzymes
|
2023 | Article | 38 |
|
Synthesis, Characterization, Bioactivity Impacts of New Anthranilic Acid Hydrazones Containing Aryl Sulfonate Moiety as Fenamate Isosteres
|
2023 | Article | 33 |
|
Synthesis, biological evaluation, and in silico study of novel library sulfonates containing quinazolin-4(3<i>H</i>)-one derivatives as potential aldose reductase inhibitors
|
2022 | Article | 90 |
|
Novel phenolic Mannich base derivatives: synthesis, bioactivity, molecular docking, and ADME-Tox Studies
|
2022 | Article | 41 |
|
Synthesis and Potentiometric Sensor Applications of a Hydrazone Derivative Molecule: Fast and Selective Determination of Cobalt(II) Ions
|
2022 | Article | 7 |